
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Embrace the Outside: Exercises and Entertainment - 2
Mysterious bright blue cosmic blasts triggered by black holes shredding stars, scientists say. 'It's definitely not just an exploding star.' - 3
How to identify animal tracks, burrows and other signs of wildlife in your neighborhood - 4
I visited the largest collection of public telescopes in the US in Oregon's high desert, and the dark skies blew me away - 5
Vote In favor of Your Favored Web-based Book Retailor
Vote in favor of the bloom plan that adds a bit of excellence to your life!
Instructions to Safeguard Your Speculations In the midst of Changing Disc Rates
As reefs vanish, assisted coral fertilization offers hope in the Dominican Republic
Taylor Momsen explains why she quit 'Gossip Girl': 'I really didn't want to be there'
Figure out How to Back Your Rooftop Substitution
Recalled Super Greens diet supplement powder sickens 45 with salmonella
The 10 Most Significant Games in History
Sally Rooney books may be withdrawn from UK sale over Palestine Action ban, court told
Brexit's Effect on New York's Ascent as a Main Monetary Center












